Gilead has spent approximately $7.1 billion to acquire Arcellx, Inc., making it a wholly owned subsidiary.
Filing excerpt
On April 28, 2026, Gilead Sciences, Inc., a Delaware corporation (“Parent” or “Gilead”), issued a press release announcing the completion of the acquisition of the Arcellx, Inc., a Delaware corporation (the “Company”)...
What this signalsIntegration work after a deal often opens needs for new systems and services.
Vendors
Vendors named
sec-8kacquisitionCompletedGet every 8-K signal for Gilead and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Gilead this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/93cb5518-e889-4c19-9156-11db31695eba returns this record as JSON. POST /v1/companies/enrich returns every signal for gilead.com.
{
"signal_id": "93cb5518-e889-4c19-9156-11db31695eba",
"signal_type": "sec-8k",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-05-05T08:48:15.984+00:00",
"company": {
"name": "Gilead",
"domain": "gilead.com"
},
"data": {
"detail": "Gilead has spent approximately $7.1 billion to acquire Arcellx, Inc., making it a wholly owned subsidiary. This major acquisition creates immediate, large-scale needs for integrating systems, data, personnel, and clinical development processes, presenting significant opportunities for vendors specializing in post-merger integration, IT consolidation, and compliance.",
"metrics": {
"timeframe": "immediate",
"dollar_context": "Total funds used to consummate the offer and merger for Arcellx, Inc.",
"dollar_millions": 7100
},
"summary": "Gilead completes $7.1B acquisition of Arcellx, Inc. to bolster its cell therapy portfolio.",
"excerpts": "On April 28, 2026, Gilead Sciences, Inc., a Delaware corporation (“Parent” or “Gilead”), issued a press release announcing the completion of the acquisition of the Arcellx, Inc., a Delaware corporation (the “Company”)...",
"relevance": 0.95,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/882095/000110465926049874/tm2612748d1_8k.htm",
"filing_date": "2026-04-28",
"filing_year": 2026,
"sales_relevance": "Active integration needs",
"signal_category": "strategic",
"vendors_mentioned": [
"Computershare, Inc.",
"Computershare Trust Company, N.A."
]
}
}
curl https://signals.autobound.ai/v1/signals/93cb5518-e889-4c19-9156-11db31695eba \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gilead.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.